Update on Transdermals for Animal Patients
Author(s): Davidson Gigi S
Issue: May/Jun 2005 - Veterinary Compounding
View All Articles in Issue
Page(s): 178-182
Download in electronic PDF format for $65
Abstract: Much insight has been gained into the disposition of transdermally administered medications to animal patients over the last 2 years. Scientific investigations are beginning to unravel the mystery of percutaneous drug disposition of transdermally applied drugs. While exact disease-specific protocols for transdermal drug therapy are yet to be determined, pulsed transdermal drug delivery in feline patients still offers much hope for life-saving, noninvasive therapeutic intervention. While the regulatory and scientific environments are still developing on the subject of pulsed transdermal therapy, this dosage form still represents one of the most promising therapeutic tools in the veterinarian’s “black bag.” By keeping pace with the results of scientific investigations in veterinary transdermal therapy and by practicing due diligence in chronicling transdermal therapeutic outcomes, the compounding pharmacist can maximally contribute to the veterinary care quadrad.
Related Keywords: Gigi Davidson, BSPh, DIVCP, transdermal preparation, percutaneous drug delivery, veterinary care